Literature DB >> 3479378

Effect of indomethacin on aqueous PGE2 levels in rabbits following ocular trauma.

C Skorpik1, P Paroussis, M Grasl, H D Gnad.   

Abstract

Using a highly specific radioimmunoassay, post-traumatic aqueous PGE2 levels were measured in rabbit eyes treated with topical indomethacin aqueous solution, as well as in untreated eyes. In two groups of ten rabbits each, the surgical trauma consisted of corneoscleral incision (without injury to the iris); one of the two groups received prophylactic treatment (3 days) and therapeutic (21 days) indomethacin treatment. In two other groups of ten rabbits each, corneoscleral incision and iridectomy were performed. One group received indomethacin treatment as described above, while the other group was not treated. Surgery was performed in all 40 right eyes, the left eyes serving as controls. In 20 of the 40 left eyes, indomethacin therapy was applied. In all right and left eyes, aqueous samples were withdrawn 3 days and 21 days postoperatively, and PGE2 concentrations were determined. The results indicate that 3 days after corneal trauma and 3 days after corneal trauma plus iridectomy, there was a highly significant reduction in the elevated PGE2 concentrations as a result of indomethacin therapy. On postoperative day 21, indomethacin reduced even further the still slightly elevated aqueous PGE2 concentrations without, however, completely blocking prostaglandin activity. The latter was observed even in the control animals that were not operated upon; they showed minimal PGE2 levels in response to corneal puncture on postoperative day 3 for the purpose of drawing aqueous samples. Our study demonstrated that short-term indomethacin therapy has a significant inhibitory effect, but no unequivocal answers were found as to the value of long-term treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3479378     DOI: 10.1007/BF02334174

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  22 in total

1. 

Authors:  R Rochels
Journal:  Doc Ophthalmol       Date:  1984-05       Impact factor: 2.379

2.  The release of PGE2-like activity into aqueous humor after paracentesis and its prevention by aspirin.

Authors:  J D Miller; K E Eakins; M Atwal
Journal:  Invest Ophthalmol       Date:  1973-12

3.  The site of action of prostaglandin E2 on the disruption of the blood-aqueous barrier in the rabbit eye.

Authors:  A H Neufeld; M L Sears
Journal:  Exp Eye Res       Date:  1973-12-10       Impact factor: 3.467

4.  A simple chemical procedure for distinguishing E from F prostaglandins, with application to tissue extracts.

Authors:  N Ambache; H C Brummer
Journal:  Br J Pharmacol Chemother       Date:  1968-05

5.  Incidence of aphakic cystoid macular edema with the use of topical indomethacin.

Authors:  L A Yannuzzi; A N Landau; A I Turtz
Journal:  Ophthalmology       Date:  1981-09       Impact factor: 12.079

6.  Prostaglandin and an increased sensitivity of the sympathetically denervated rabbit eye to laser-induced irritation of the iris.

Authors:  W G Unger; J M Butler; D F Cole
Journal:  Exp Eye Res       Date:  1981-06       Impact factor: 3.467

7.  Prevention of cystoid macular edema after lens extraction by topical indomethacin (III) radioimmunoassay measurement of prostaglandins in the aqueous during and after lens extraction procedures.

Authors:  K Miyake; S Sugiyama; I Norimatsu; T Ozawa
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-12-15

8.  Species variations in the pathophysiologic responses of vertebrate eyes to a chemical irritant, nitrogen mustard.

Authors:  E M Klein; L Z Bito
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-02       Impact factor: 4.799

9.  [Prevention of cystoid macular edema using indomethacin eye drops].

Authors:  F Hollwich; K Jacobi; H J Küchle; W Lerche; M Reim; W Straub
Journal:  Klin Monbl Augenheilkd       Date:  1983-12       Impact factor: 0.700

10.  Aqueous penetration of oral and topical indomethacin in humans.

Authors:  D R Sanders; B Goldstick; C Kraff; R Hutchins; M S Bernstein; M A Evans
Journal:  Arch Ophthalmol       Date:  1983-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.